About Genetiks
Our Vision & Mission
History
Administrative Structure
Quality Policy
Certificates
Licences
Publications
Proceedings
All Services
OnkoGENETiKS
General Information
Next Generation Oncology
CGP (Comprehensive Genomic Profiling)
Liquid Biopsy
Hereditary Cancer Panels
Breast and Ovary Cancer Panel
Conventional Oncology Tests
ReproGenetiks
Preimplantation Genetic Tests (PGT)
Prenatal Tests
Preconceptional Genetic Testing
Sperm FISH
TUNNEL Test (Sperm fragmentation)
Peripheral Karyotyping
Y Microdeletion
Thrombophilia panel
Endometrial Receptivity & Microbiome Analysis
Rare/Pediatric Disorders
CES (Clinical exome sequencing)
WES (Whole exome sequencing)
WGS (Whole genome sequencing)
Microarray
Microdeletion&Duplication Syndromes
Mutation Analysis
Gene Sequencing
PharmacoGENETiKS
Drug sensitivity/Dose setting
Toxicity/Targeted therapy
Toxicity
Immunotherapy/Targeted Therapy
Wellness
Cardiovascular Risk Panel
NutriGenetiks
Sport Genetics
Genetic Counselling
Types of Genetic Disorders
What is the Genetic Counseling Process?
Who Should Consider Genetic Counseling?
Genetic Counseling Specialties
Request Forms
Consent Forms
Sample Sending
ABOUT US
SERVICES
FIND TEST
FORMS
ONLINE REPORTS
Test Search
News
Contact
Spinal Muscular Atrophy (SMA) is clinically characterized by progressive muscle weakness depending upon the degeneration in the anterior horn cells of spinal cord and cranial nerve nuclei.
SMN gene causing the disease is localized at the long arm of (5q13) of chromosome 5. Around 95-98 % of patients have homozygous deletions at exons 7and 8 regions of SMN-1 gene. For about 2-5 % of the patients a compound heterozygosity at exons 7 and 8 or point mutations are detected.
Terrace Fulya Center 2, Teşvikiye, Hakkı Yeten Cd. No:13 Kat M4, 34365 Şişli / İstanbul / Turkey
©2024 Genetiks. All rights reserved.